Translational Medicine-2013 will cover current and emerging challenges in the biopharmaceutical industry and strategies for drug development. Current strategies and processes for drug discovery and development within the pharmaceutical industry are contrasted with the adoption of Translational Medicine research strategies. Translational Medicine-2013 considers the requirements of various medical advances in terms of innovative strategic approaches to deliver advances to patients, and the contrasting requirements for effective translation in commercial companies and health services. It will cover integration across scientific, medical and socio-economic disciplines.